3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Rectal Neoplasms
1
Pancreatic Cancer Resectable
1
Ovarian Carcinosarcoma
1
Neoplasms
1
Liver Neoplasms
1
Immune-related Adverse Event
1
Esophageal Neoplasms
1
Early Hormone Receptor-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Solid Tumor
1
Interventions
niraparib
1
dostarlimab
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ovarian Carcinosarcoma
×
Antineoplastic Agents
×
Clear all
NCT03651206
2026-06-01
ROCSAN
ARCAGY/ GINECO GROUP
Phase 2/3
Recruiting
138 enrolled